Catalysts About TELA Bio TELA Bio develops and commercializes soft tissue repair and reconstruction products, including the OviTex and OviTex PRS portfolios for hernia, abdominal wall and plastic surgery procedures. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About TELA Bio TELA Bio develops and commercializes next generation soft tissue repair and reconstruction solutions for hernia and plastic and reconstructive surgery. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About TELA Bio TELA Bio develops and commercializes soft tissue repair and reconstruction solutions, including reinforced tissue matrices for hernia and plastic and reconstructive surgery. What are the underlying business or industry changes driving this perspective?Read more
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
